Generex Biotechnology (OTCMKTS:GNBT) Stock Price Passes Above 200 Day Moving Average of $1.82

Generex Biotechnology Co. (OTCMKTS:GNBT) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.82 and traded as high as $2.17. Generex Biotechnology shares last traded at $2.17, with a volume of 33,622 shares traded.

Separately, ValuEngine cut shares of Generex Biotechnology from a “buy” rating to a “hold” rating in a report on Tuesday, July 2nd.

The firm’s fifty day simple moving average is $2.65 and its 200 day simple moving average is $1.82.

Generex Biotechnology (OTCMKTS:GNBT) last announced its earnings results on Wednesday, June 19th. The company reported ($0.17) EPS for the quarter. The business had revenue of $1.09 million for the quarter.

About Generex Biotechnology (OTCMKTS:GNBT)

Generex Biotechnology Corporation, through its subsidiaries, primarily engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an insulin formulation administered as a fine spray into the oral cavity.

Featured Article: What is required to own or exchange cryptocurrency?

Receive News & Ratings for Generex Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Generex Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.